付費(fèi)下載
下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
預(yù)測及評價化療療效ApparentDiffusionCoefficient:PotentialImagingBiomarkerforPredictionandEarlyDetectionofResponsetoChemotherapyinHepaticPro.Xiaopeng臨床腫瘤學(xué)市腫瘤防BeijingCancerPekingUniversitySchoolofBeijingInstituteforCancerDiffusionWeighted- DiffusioniscausedbyrandommolecularTheamountofdiffusionisdeterminedbydiffusionDiffusionWeighted- Diffusion-weightedimaging(DWI)istheonlymethodtoproberandommicroscopicmotionofwaterprotonsonaperpixelbasisinvivoDiffusionWeighted-測量組織的擴(kuò)散系數(shù)受到眾多因素影響,例 Themeasurementofthediffusioncoefficientinvivomaybeaffectedbyfactorsotherthantruediffusion,e.g.temperature,perfusion,magneticsusceptibilityinthetissue,orotherkindsofmotionThetermapparentdiffusioncoefficient(ADC)ratherthandiffusioncoefficientisusedDiffusionWeighted-TheADCisstronglyaffected分子黏滯性(molecular細(xì)胞內(nèi)外膜結(jié)構(gòu)的通透性 permeabilityofmembraneseparatingtheintra-and組織/細(xì)胞結(jié)構(gòu)的方向(thedirectionalityoftissuecellularstructuresthatimpedewaterHernethAM,GuccioneS,BednarskiM.EurJRadiol2003;45:208–213.KauppinenRA.NMRBiomed2002;15:6–17.ChenevertTL,StegmanLD,TaylorJM,etal.JNatlCancerInstLyngH,HaraldsethO,RofstadEK.MagnResonMedDiffusionWeighted-ClincialUnderstandingofnormalandCharacterizingfocalanddiffuseMonitoringtherapy化療/放病灶TheCNRofHCCwashigherDWIthanin TheCNRofHCCwashigherinDWIthanin與鑒IchikawaT,etal.AJR,ChanJH,etal.AbdomImaging,2001,26(2):161-Cyst
HemangiomaADC=1.21×10-3
HCC肝細(xì)胞ADC=0.94×10-3 ThresholdADCvalueforthediagnosisofIchikawa以5.5×10-3mm2/sIchikawaT,etal.AJR,1998,170(2):397-402KimT,etal.AJR,1999,173(2):393-8.TaouliB,etal.Radiology,2003,226(1):71-療效 Kamel:DWIcouldbeusefultoolsinassessmentoftumorresponseafterKamelIR,JVascIntervRadiol,2006;17,3:505-療效KamelIR,JVascIntervRadiol,2006;17,3:505-療效 Theilmann:Atotalof13patientswithmetastaticbreastcancerand60measurableliverlesionsweremonitoredbydiffusionMRIafterinitiationofnewcoursesofchemotherapy治療早期ADC值與腫瘤對治療反映具有明顯相可以通過DWI預(yù)測乳癌肝轉(zhuǎn)移瘤diffusionMRIcanpredictresponseearlyTheilmannRJ,etal.Neoplasia,2004,6(6):831-TheilmannRJ,etNeoplasia,療效 Hepaticmetastasesarethemostcommonmalignantneoplasmoftheliverandmostofthemarerelatedwithgastrointestinalcancer化療是最為常用的治ChemotherapyisroutinelyusedtomanagetheandimprovetheDWOnlyfewofthemfocusedontheuseofDW-MRIfordetectingtheresponseofcolorectalandgastrichepaticmetastasestochemotherapy.WagnerAD,GrotheW,HaertingJ,etal.JClinOncol2006;24:2903-Our研究Theaimofthisstudyistoevaluatetheabilityoftheapparentdiffusioncoefficient(ADC)topredictresponsetochemotherapyinpatientswithcolorectalandgastrichepaticmetastases.材料 trymetastasesfromgastrointestinal肝內(nèi)至少一個可測病灶withaminimumofonelivermetastasesmeasuringthan1 KPS評分Karnofskyperformancescale(KPS)>scheduledtoinitiateanewchemotherapy材料 Theprotocolinourstudywasapprovedbyourinstitutionalreviewboard,andinformedconsentwasobtainedfromallpatients.材料 MRIbaselineandthenat3,7and42daysafterthebeginningof1.5-TMRscanner(SignaExciteII;GEMS,Milwaukee,WI,USA)T1WI,T2WI,DWI(b=0,800sec/mm2材料 專業(yè)工作站(AW4.2GEMS,USAFunctool軟件GEMS,USA)測量病灶大小、ADClesionsizeand計(jì)算ADC升高率:percentageADC%ΔADCN=(ADCN-ADCB)/ADCB大小退縮率:Tumorsizechanges(%ΔV42%ΔV42=(VB–V42)/V病灶反應(yīng)性評估23例患者8723patientsevaluated,atotalof87 各監(jiān)測點(diǎn)監(jiān)測病灶數(shù)NumberoflesionsscanedateachtimeNumberNumberTotalDayDayDayCharacteristicorCharacteristicor CharacteristicorNumberof 748411-Numberof748411-NumberoflivermetastaticFemale: Primary9Colorectal9Well 5531 axel+5531 axel+ axel+Cisplatin+5-Capecitabine+Irinotecan+CalciumNumberofpriorchemotherapyPoorly Gastric y 4Poorly4MeanonsetofMeanonsetoflivermetastasisaftertheprimarytumordiagnose(range)[months]11Thirty-eightlesionsrespondedtochemotherapyand49did化療各監(jiān)測點(diǎn)病灶平 umdiameterofrespondingandnonrespondinglesionsateachtimepointofDayDayDay
mm(+
mm(+
p化療各監(jiān)測點(diǎn)病灶平均ADCADCvaluesinrespondingandnonrespondinglesionsateachtimepointofp10-10-DayDayDay,化療中,兩組病灶平均ADC值均明顯升高(F反應(yīng)良好F反應(yīng)不良=5.512,P<0.001反應(yīng)良好組在化療中各個時間點(diǎn)平均應(yīng)不良組(F167P0001)3days:25.4%vs.7.2%;7days:26.2%vs.大小退縮率弱相關(guān)(Day3,r-value=0.344,p=0.004;Day7,r-value=0.423,p<0.001).AweakbutsignificantpositivecorrelationwasobservedbetweenpercentagereductioninlesionsizeandpercentageADCincreaseatDays3and7(Day3,r-value=0.344,p=0.004;Day7,r-value=0.423,p<0.001).AnearlyincreaseinmeanADCsandlowpre-therapymeanADCsinhepaticmetastasesfromgastricandcolorectalcarcinomasmaybeapredictorofresponsetochemotherapy.相關(guān)基礎(chǔ)研Theuseoftheapparentdiffusioncoefficient(ADC)ofwateracquiredbydiffusion-weighted(DW)MRIasasurrogatemarkeroftissuecellularityispotentiallyItiswidelyheldthattumorADCvaluesincreasefollowingsuccessfultreatment,reflectingareductionincellulardensityandbarrierstowatermotion.相關(guān)基礎(chǔ)研AnumberofanimalandcellmodelshaveindicatedthatincreasesinADCwereassociatedwithtreatment-inducedtumorregression,suchas兔VX2腫瘤模型:ADC值可反映不同區(qū)域病理差異,壞死區(qū)ADC值明顯高周邊無壞死區(qū)域VX2RabbitLiverTumorMode:ADCvaluesatthenecroticcoreofeachtumorweresignificantlygreaterthatattheviableperipheryofeachcorrespondingJieDeng,etal.InvestRadiol2006;41:相關(guān)基礎(chǔ)研d等發(fā)現(xiàn)兔腫瘤模型ADCGeschwind:ADCsweresignificantlygreaterintheareaoftumornecrosisthanintheareaofviabletumorinVX2tumorrabbitsmodelafterTACE. presenceofgreateramountsofextracellularwaterwithinthenecroticregioncausedbycelllysisandleakiercellmembranesthatcannolongercompartmentalizewatermolecules,whichallowfreediffusiontotakeplaceshrinkageofapoptoticcells,whichwouldresultinanincreaseinextracellularwaterGeschwindJF,etal.JVascIntervRadiol,2000,11(10):1245-.Inthecontrolanimal,theareaoftumornecrosisisidentifiedasabrightzone,reflectingincreaseddiffusionofwatermoleculescausedbybreakdownofcellmembranes.Awell-definedrimoflowsignalisalsoidentified,reflectingintactcellmembranesandrestrictionofwatermolecules,consistentwithviabletumorcells.Inthetreatedanimal,signalthroughoutthetumorishomogenousandbrighterthaninnormalmuscletissue,indicatingnearlycompletenecrosis.GeschwindJF,etal.JVascIntervRadiol,2000,11(10):1245-Our ChangesofADCvaluesandPathologicalParametersinMurineTumorAfter結(jié)果療后ADC值亦較前減低:4、8小時組腫瘤,鏡 ADCvaluefallingearlyaftertherapy(4,8,12h)isassociatewithedema,vascularcongestion,hemorrhageanddegenerationofthecellulose結(jié)果4小時ADC值變化率:-TheADCchangesinfourhoursaftertherapy-17.64%HEstain:Vascularengorgement結(jié)果8小時ADC值變化率:-TheADCchangesineighthoursaftertherapy45.94%HEstain:cellularedema12小時組ADC值變化率:-TheADCchangesintwelvehoursaftertherapy:- HEstain:Vascularengorgement,hemorrhageseriouslyand結(jié)果ADCvalueshavecertaincorrelationswithapoptosisindex(AI)andthepercentageofproliferation(PI)withinthetumortissue:ADCchangeshavemoderatepositivecorrelationwithapoptosispercentageandmoderatenegativecorrelationwithproliferationpercentage;theinitialADCvalueisnegativecorrelatedwithapoptosisandpositivecorrelatedwithproliferation.療前Pre-therapy
療后Post-therapy Ki67
TUNEL結(jié)果CorrelationinADCchangesandapoptosisADCchangesADCchangesPearsonSig.(2-N PearsonN
.
1.結(jié)果CorrelationinADCchangesandpr
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 幼兒園疫情防控演練方案
- EPS制作安裝施工方案
- 開學(xué)工作方案
- 印章管理制度
- 中小學(xué)升國旗制度
- 河道清淤施工方案
- 公路瀝青路面施工監(jiān)理報告
- 廣告牌制作方案
- 企業(yè)薪酬管理與激勵方案設(shè)計(jì)
- 企業(yè)文化建設(shè)與員工凝聚力提升方案案例
- 能源與動力工程專業(yè)培養(yǎng)目標(biāo)合理性評價分析報告
- 公司員工活動室管理制度
- CJ/T 3066-1997內(nèi)磁水處理器
- 院內(nèi)急重癥快速反應(yīng)小組
- 湖南省省情試題及答案
- 幕墻玻璃板塊平整度檢查
- 船舶與海上技術(shù) 海上安全 氣脹式救生裝置用充氣系統(tǒng) 征求意見稿
- 紅巖中考試題及答案
- 人民幣銀行結(jié)算賬戶工作指引
- 產(chǎn)房護(hù)士年終工作總結(jié)模版
評論
0/150
提交評論